Human papillomavirus type 16 and 18 E7-pulsed dendritic cell vaccination of stage IB or IIA cervical cancer patients: a phase I escalating-dose trial

[Effects of intratumoral injection therapy of dendritic cells combined with hyperthermia for cancer patients]

Phase I/II clinical trial of sequential subcutaneous and intravenous delivery of dendritic cell vaccination for refractory multiple myeloma using patient-specific tumour idiotype protein or idiotype (VDJ)-derived class I-restricted peptides

[Dendritic cells pulsed with glioma RNA induce immunity against intracranial gliomas]

The ‚kiss of death‘ by dendritic cells to cancer cells

Numerical and functional defects of blood dendritic cells in early- and late-stage breast cancer

Regression of intestinal adenomas by vaccination with heat shock protein 105-pulsed bone marrow-derived dendritic cells in Apc(Min/+) mice

Localized hyperthermia combined with intratumoral dendritic cells induces systemic antitumor immunity

A combination of chemoimmunotherapies can efficiently break self-tolerance and induce antitumor immunity in a tolerogenic murine tumor model

Therapeutic dendritic cell vaccination with Ag coupled to cholera toxin in combination with intratumoural CpG injection leads to complete tumour eradication in mice bearing HPV 16 expressing tumours